Malakoff Humanis Innov'
MH Innov' is the corporate venture capital fund of the Malakoff Humanis Group, launched in 2018 with a capital of 250 million euros. It invests in innovative startups shaping the future of health and insurance, supporting about 30 startups and collaborating with partners like Eurazeo and Elaia.
Key facts
Recent exits
Coverage notes
1 fund tracked, 20 portfolio companies (16 active · 4 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
20 companiesFunds & portfolio
Every fund Malakoff Humanis Innov' has raised, with its portfolio companies. Hand-checked from public filings.
MH Innov'VCharvesting2018 · 8yr€250M16 active · 4 realized
Unrealized
16 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| SaaS |  France | 2019 | |
| SaaS | France | 2022 | |
| SaaS | France | 2021 | |
| HealthTech | France | 2018 | |
| HealthTech | France | 2023 | |
| Software | France | 2022 | |
| SaaS | France | 2021 | |
| HealthTech | France | 2018 | |
| Healthcare | France | 2021 | |
| HealthTech | France | 2024 | |
| InsurTech | France | 2025 | |
| SaaS | France | 2019 | |
| HealthTech | France | 2024 | |
| LegalTech | France | 2019 | |
| InsurTech |  Germany | 2021 | |
| Biotech | France | 2021 |
France· Entry 2019France· Entry 2022France· Entry 2021France· Entry 2018France· Entry 2023France· Entry 2022France· Entry 2021France· Entry 2018France· Entry 2021France· Entry 2024France· Entry 2025France· Entry 2019France· Entry 2024France· Entry 2019Germany· Entry 2021France· Entry 2021Realized
4 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| – | – | 2020 | 2023 | Trade Sale | – | ||
| – | – | 2021 | 2022 | Trade Sale | – | ||
| – | – | 2020 | 2022 | Trade Sale | – | ||
| Healthcare | France | 2020 | 2025 | Trade Sale | – |
Saved GPs appear in your watchlist, one click from your workspace.
About Malakoff Humanis Innov'
MH Innov' is the corporate venture capital fund of the Malakoff Humanis Group, launched in 2018 with €250 million of capital. The fund invests in innovative startups shaping the future of health and insurance, supporting approximately 30 startups and collaborating with the Malakoff Humanis health and protection insurance ecosystem from Paris.
Investment thesis
MH Innov' targets European startups across HealthTech, InsurTech, digital health and selective wellness verticals aligned with Malakoff Humanis's core health and protection insurance mandate. The corporate VC structure provides strategic relationships with one of France's largest health insurance groups, supporting portfolio company commercial development with French insurance distribution and health partner networks. Equity tickets vary by stage from venture-stage early commitments through to growth-stage follow-on investments.
Recent activity
Recent realised exits include CetteFamille (healthcare, 2025) and Health for People (healthcare, 2024), reflecting selective distribution across the corporate VC portfolio. The platform tracks a single dedicated fund and 10 active portfolio companies across the health-themed venture programme. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
France·€260M
France·€240M
France·€230M
France·€228M
France·€280M
France·€280M
France·€210M
France·€300M
France·€200M
France·€190M
France·€311M
France·€320MGet the full picture on Malakoff Humanis Innov'.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in